Metro Medical Supply, Inc. v. Shalala

959 F. Supp. 799, 1996 U.S. Dist. LEXIS 20819, 1996 WL 865387
CourtDistrict Court, M.D. Tennessee
DecidedDecember 12, 1996
DocketNo. 3:96-1075
StatusPublished

This text of 959 F. Supp. 799 (Metro Medical Supply, Inc. v. Shalala) is published on Counsel Stack Legal Research, covering District Court, M.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Metro Medical Supply, Inc. v. Shalala, 959 F. Supp. 799, 1996 U.S. Dist. LEXIS 20819, 1996 WL 865387 (M.D. Tenn. 1996).

Opinion

ORDER

CAMPBELL, District Judge.

This is a civil action to enjoin a criminal investigation and prosecution.

Pending before the Court are the following Motions: Motion for Preliminary Injunction (Docket No. 2); Emergency Motion For Expedited Temporary Injunction Hearing (Docket No. 7); Motion To Quash Subpoena (Docket No. 15); and Defendant’s Response To Plaintiffs’ Motion For Preliminary Injunction And Request That Plaintiffs’ Verified Complaint Be Dismissed For Failure To State A Claim Upon Which Relief May Be Granted (Docket No. 9).

The Court held a hearing on all pending motions on December 11, 1996. For the reasons described herein, the Court rules on the pending Motions as follows:

The Motion For Preliminary Injunction (Docket No. 2) is DENIED. The Emergency Motion For Expedited Temporary Injunction Hearing (Docket No. 7) is DENIED as to the relief requested, but GRANTED to the limited extent that the Court held a hearing on December 11, 1996. The Motion To Quash Subpoena (Docket No. 15) is DENIED as moot. The Court found the proffered testimony of Earl Davis and Larry Loftis unnecessary to a determination of the Motion For A Preliminary Injunction.1 The request that Plaintiffs’ Verified Complaint be dismissed for failure to state a claim upon which relief may be granted (Docket No. 9) is held under advisement until the Plaintiffs have an opportunity to file a written response in accordance with Local Rule 8(b)(3).

I. INTRODUCTION

Metro Medical Supply, Inc., Bart Ashley, and F.H. Thompkins, III have filed a Complaint asking for certain declaratory and in-junctive relief. F.H. Thompkins subsequently filed a notice of voluntary dismissal and is no longer a party.

The Complaint asks this Court to “enter a preliminary injunction, after notice and hear[801]*801ing, in which Defendants are enjoined from enforcement of the PDMA/PDA of 1992, 21 U.S.C. § 353(e)(1)(A), including any criminal investigation or criminal prosecution, as to these Plaintiffs only, until such time as the Court declares the rights of the parties” (Docket No. 1, p. 18) (emphasis added).

Exhibit 8 to the Complaint indicates that the United States Attorney is also investigating Metro Medical Supply, Inc. for certain other alleged offenses (e.g., wire fraud, money laundering, forfeiture).

Plaintiffs subsequently moved this Court for a preliminary injunction enjoining the Defendants from investigating and/or prosecuting them with respect to any alleged violations of the Prescription Drug Marketing Act of 1987 (“PDMA”), as amended by the Prescription Drug Amendments of 1992 (“PDA”), including but not limited to violations of 21 U.S.C. §§ 331(t) or 353(e). For grounds, the Plaintiffs state that:

(1) Unless restrained by this court, the defendants will continue their ongoing criminal investigation of the plaintiffs and it is reasonably believed will wrongfully attempt to criminally prosecute the plaintiffs for asserted violations of the PDMA as amended by the PDA, including but not limited to 21 U.S.C. §§ 331(t) and 353(e);
(2) Such actions by the defendants will result in irreparable injury, loss and damages to the plaintiffs, as more particularly appears in the Verified Complaint, filed simultaneously herewith;
(3) The issuance of a preliminary injunction as requested will not cause undue inconvenience or loss to the defendants but will prevent irreparable injury to the plaintiffs;
(4) The plaintiffs are likely to succeed on the merits in a trial on this declaratory judgment claim; and,
(5) The issuance of the requested preliminary injunction is likely to advance the public interest.

(Docket No. 2).

Defendants in this case are Donna E. Sha-lala, Secretary of the Department of Health and Human Services; Dr. David Kessler, Commissioner of the Food and Drug Administration; Janet Reno, Attorney General of the United States; and John M. Roberts, United States Attorney for the Middle District of Tennessee.

Plaintiffs then filed an Emergency Motion For An Expedited Hearing (Docket No. 7) (“Emergency Motion”). In the Emergency Motion, Plaintiffs essentially restate their Motion For A Preliminary Injunction and add an alternative request. Plaintiffs, alternatively, request that this Court quash the grand jury subpoena of F.H. Thompkins until such time as a hearing on Plaintiffs’ “motion for a temporary injunction may be had” (Docket No. 7). Plaintiffs also request a continuation of the grand jury proceeding to evaluate a potential conflict of interest with counsel.

At the time the Plaintiffs’ Motions were filed, F.H. Thompkins was scheduled to give his grand jury testimony on December 11, 1996 at 1:00 p.m. The Government’s Response indicates that the testimony has now been continued thirty days. Moreover, as discussed above, F.H. Thompkins is no longer a party.

The PDMA and PDA contain certain provisions that require a paper trail for the sales history of certain prescription drugs. This is commonly referred to as a “pedigree.” Plaintiffs claim that the pedigree provisions of the PDMA and PDA are unconstitutional on two grounds. First, Plaintiffs assert that the pedigree provisions are unconstitutionally void for vagueness under the Fifth Amendment of the Constitution. Second, Plaintiffs aver that the pedigree provisions constitute an unconstitutional delegation of legislative authority, under Article I, Section 1, of the Constitution, to the FDA and, in turn, to private drug manufacturers.

Plaintiffs allege that they are suffering irreparable injury from the ongoing grand jury investigation and threat of prosecution because they are losing business, suffering damage to their reputations, and that there is a negative impact on a possible sale of Metro Medical Supply, Inc. stock.

Plaintiffs have asked the Court to declare the relevant pedigree provisions of the PDMA and PDA unconstitutional and to en[802]*802join the Defendants from any further criminal investigation or prosecution of them until such time as the Court declares the rights of the parties.

II. MOTION TO ENJOIN CRIMINAL INVESTIGATION AND PROSECUTION

Obtaining an injunction against a criminal investigation or prosecution is very difficult. Courts are extremely reluctant to enjoin criminal investigations and prosecutions. This Court has found no published decision in which a court enjoined an ongoing federal criminal investigation under similar circumstances. Dicta exist, however, suggesting that a prosecutor could be enjoined for repeatedly engaging in illegal or unconstitutional actions. Paul S. Diamond, Federal Grand Jury Practice and Procedure § 401[E] (3rd ed.1995). The reluctance of federal courts to enjoin criminal investigations and prosecutions is well founded.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. R. Enterprises, Inc.
498 U.S. 292 (Supreme Court, 1991)
C.W. Blalock, Jr. v. United States
844 F.2d 1546 (Eleventh Circuit, 1988)
North v. Walsh
656 F. Supp. 414 (District of Columbia, 1987)
Boggs v. Bowron
842 F. Supp. 542 (District of Columbia, 1993)
Thomas by and Through Thomas v. Davidson Academy
846 F. Supp. 611 (M.D. Tennessee, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
959 F. Supp. 799, 1996 U.S. Dist. LEXIS 20819, 1996 WL 865387, Counsel Stack Legal Research, https://law.counselstack.com/opinion/metro-medical-supply-inc-v-shalala-tnmd-1996.